Tenshi Kaizen has also invested in Olene Life Science (Olene), an India based pure-play innovation-driven company with a focus on novel natural products both for human and animal health use.
Olene’s patented platform technology Aquasome® is developed to deliver concentrated, highly bioavailable and sustained released phytochemicals for long-lasting and greater therapeutic benefits.
As of Feb 2020, Olene has 13 industry-leading patents including 4 platform technologies for application in human and animal nutrition. The Company’s patented Curcumin product, Turmeric T5 ComplexTM delivers the highest concentration of free curcumin to blood plasma and its Ginger product, Gingene®, contains the highest concentration of 6-Gingerols thereby reducing the dose to a 1-a-day capsule without compromising the therapeutic benefits. Olene is also working on an age-related macular degeneration (AMD) product which is poised to be the world’s first patented nutraceutical product to target wet AMD in humans.
For feed animal use, Olene’s product NitriGen, a patented Slow Release non-protein nitrogen product, is one of the world’s best non-protein nitrogen sources for Ruminants. The Company is also working on developing Rumen bypass products such as lysine, methionine, sodium butyrate, vitamins and minerals on its patented platform technology.